Skip to main content

AACE 2024 Annual Meeting Main banner

Tweets by AACE 2024 Annual Meeting

Cardiometabolic and Lipids

Efficacy Of SGLT-2 Inhibitors And GLP-1 Receptor Agonists In Patients With MASLD

Thursday, May 9, 2024

11:30 AM – 12:15 PM CDT

Location: Storyville Hall, Level 3

CE: 0.75

CME/CE/MOC Credit

On-Demand Available For This Session

Learning Objectives:

Understand the Prevalence and Pathophysiology of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
Explore the Effects of Incretins on Metabolic Dysfunction and Liver Health
Evaluate the Impact of SGLT-2 Inhibitors in the management of MASLD

Speaker(s)

Aman Rajpal, MD, DABOM (he/him/his)

Chief, Division of Endocrinology
Alameda Health System
South San Francisco, California, United States

Slides

Moderator(s)

Kenneth Izuora, MD, MBA, FACE

Chief, Division of Endocrinology and Program Director, Endocrinology Fellowship Training Program
University of Nevada Las Vegas
Las Vegas, Nevada, United States